Identification of the immunodominant regions of the melanoma antigen tyrosinase by anti-tyrosinase monoclonal antibodies

Melanoma Research

Volumn 13, Issue 5, 2003, Pages 473-482

  Jaanson, Nele ^a   Möll, Kaidi ^a   Kulla, Andres ^b   Ustav, Mart ^a,c  

^a UNIVERSITY OF TARTU   (Estonia)

^b TARTU UNIVERSITY CLINICS   (Estonia)

^c NONE   (Estonia)

Author keywords

Epitope mapping; Immunocytochemistry; Immunodominant region; Immunohistochemistry; Melanoma; Monoclonal antibodies; Tyrosinase

Indexed keywords

AMINO ACID; ENZYME ANTIBODY; EPITOPE; MELANOMA ANTIGEN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; MONOPHENOL MONOOXYGENASE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN BINDING; ARTICLE; BASEMENT MEMBRANE; CARBOXY TERMINAL SEQUENCE; CERCOPITHECIDAE; CONTROLLED STUDY; CROSS REACTION; EPITOPE MAPPING; ESCHERICHIA COLI; EXPRESSION VECTOR; FEMALE; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNODETECTION; MELANOCYTE; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; BASEMENT MEMBRANE; BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COS CELLS; DNA; DNA, COMPLEMENTARY; EPITOPE MAPPING; EPITOPES; HUMANS; HYBRIDOMAS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MELANOMA; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MONOPHENOL MONOOXYGENASE; PEPTIDES; POLYMERASE CHAIN REACTION; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 0142025375     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200310000-00006     Document Type: Article

References (47)

1. Robb DA. Tyrosinase. In: Lontie R (editor): Copper Proteins and Copper Enzymes, vol. 2. Boca Raton: CRC Press; 1984, pp. 207-241.
2. Pawelek JM, Chakraborty AK. The enzymology of melanogenesis in the pigmentary system and its disorders. In: Norlund JJ, Boissy, RE, Hearing, VJ, King, RA, Ortonne, J-P (editors): The Pigmentary System: Physiology and Pathophysiology. New York: Oxford University Press; 1998, pp. 391-400.
3. Oetting WS. The tyrosinase gene and oculocutaneous albinism type 1 (OCA1): a model for understanding the molecular biology of melanin formation. Pigment Cell Res 2000; 13:320-325.
4. Korner A, Pawelek J. Mammalian tyrosinase catalyzes three reactions in the biosynthesis of melanin. Science 1982; 217:1163-1165.
5. Ponnazhagan S, Hou L, Kwon BS. Structural organization of the human tyrosinase gene and sequence analysis and characterization of its promoter region. J Invest Dermatol 1994; 102:744-748.
6. Giebel LB, Strunk KM, Spritz RA. Organization and nucleotide sequences of the human tyrosinase gene and a truncated tyrosinase-related segment. Genomics 1991; 9:435-445.
7. Kwon BS, Haq AK, Pomerantz SH, Halaban R. Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus. Proc Natl Acad Sci USA 1987; 84:7473-7477.
8. Tomita Y. The molecular genetics of albinism and piebaldism. Arch Dermatol 1994; 130:355-358.
9. Takeda A, Tomita Y, Matsunaga J, Tagami H, Shibahara S. Molecular basis of tyrosinase-negative oculocutaneous albinism. A single base mutation in the tyrosinase gene causing arginine to glutamine substitution at position 59. J Biol Chem 1990; 265:17792-17797.
10. Oetting WS, Fryer JP, King RA. Mutations of the human tyrosinase gene associated with tyrosinase related oculocutaneous albinism (OCA1). Mutations in brief no. 204. Hum Mutat (Online) 1998; 12:433-434.
11. Brichard V, Van Pel A, Wolfel T, Wolfel C, De Plaen E, Lethe B, et al. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1993; 178:489-495.
12. Bancroft JD, Cook HC. Manual of Histological Techniques and Their Diagnostic Application. New York: Churchill Livingstone; 1994.
13. Chen YT, Stockert E, Tsang S, Coplan KA, Old LJ. Immunophenotyping of melanomas for tyrosinase: implications for vaccine development. Proc Natl Acad Sci USA 1995; 92:8125-8129.
14. Robbins PF, el-Gamil M, Kawakami Y, Stevens E, Yannelli JR, Rosenberg SA. Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res 1994; 54:3124-3126.
15. Topalian SL, Rivoltini L, Mancini M, Markus NR, Robbins PF, Kawakami Y, et al. Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene. Proc Natl Acad Sci USA 1994; 91:9461-9465.
16. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-254.
17. Kaldalu N. Monitoring and purification of proteins using bovine papillomavirus E2 epitope tags. Biotechniques 2000; 28:456-460, 462.
18. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning - A Laboratory Manual. New York: Cold Spring Harbor Laboratory Press; 1989.
19. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76:4350-4354.
20. Kurg R, Parik J, Juronen E, Sedman T, Abroi A, Liiv I, et al. Effect of bovine papillomavirus E2 protein-specific monoclonal antibodies on papillomavirus DNA replication. J Virol 1999; 73:4670-4677.
21. Ustav M, Ustav E, Szymanski P, Stenlund A. Identification of the origin of replication of bovine papillomavirus and characterization of viral origin recognition factor E1. EMBO J 1991; 10:4321-4329.
22. Harlow E, Lane, D. Using Antibodies. New York: Cold Spring Harbour Laboratory Press; 1999.
23. Bouchard B, Vijayasaradhi S, Houghton AN. Production and characterization of antibodies against human tyrosinase. J Invest Dermatol 1994; 102:291-295.
24. Sturm A, Box N, Ramsay M. Human pigmentation genetics: the difference is only skin deep. Bioessays 1998; 20:712-721.
25. Vijayasaradhi S, Xu Y, Bouchard B, Houghton AN. Intracellular sorting and targeting of melanosomal membrane proteins: identification of signals of the human brown locus protein, gp 75. J Cell Biol 1995; 130:807-820.
26. Simmen T, Schmidt A, Hunziker W, Beermann F. The tyrosinase tail mediates sorting to the lysosomal compartment in MDCK cells via a dileucine and a tyrosine-based signal. J Cell Sci 1999; 112:45-53.
27. McEwan M, Parsons PG, Moss DJ. Monoclonal antibody against human tyrosinase and reactive with melanotic and amelanotic melanoma cells. J Invest Dermatol 1988; 90:515-519.
28. Hearing VJ, Ekel TM, Montague PM. Mammalian tyrosinase: isozymic forms of the enzyme. Int J Biochem 1981; 13:99-103.
29. Tomita Y, Hariu A, Kato C, Seiji M. The possible processing of tyrosinase in the Golgi complexes of the melanocyte. J Dermatol 1985; 12:43-46.
30. Shibahara S, Tomita Y, Tagami H, Muller RM, Cohen T. Molecular basis for the heterogeneity of human tyrosinase. Tohoku J Exp Med 1988; 156:403-414.
31. Ruppert S, Muller G, Kwon B, Schutz G. Multiple transcripts of the mouse tyrosinase gene are generated by alternative splicing. EMBO J 1988; 7:2715-2722.
32. Porter S, Mintz B. Multiple alternatively spliced transcripts of the mouse tyrosinase- encoding gene. Gene 1991; 97:277-282.
33. Calvo PA, Frank DW, Bieler BM, Berson JF, Marks MS. A cytoplasmic sequence in human tyrosinase defines a second class of di-leucine-based sorting signals for late endosomal and lysosomal delivery. J Biol Chem 1999; 274:12780-12789.
34. Toyofuku K, Wada I, Hirosaki K, Park JS, Hori Y, Jimbow K. Promotion of tyrosinase folding in COS 7 cells by calnexin. J Biochem (Tokyo) 1999; 125:82-89.
35. Petris MJ, Strausak D, Mercer JF. The Menkes copper transporter is required for the activation of tyrosinase. Hum Mol Genet 2000; 9:2845-2851.
36. Dell'Angelica, E. Mullins C, Caplan S, Bonifacino J. Lysosome-related organelles. FASEB J 2000; 14:1265-1278.
37. Halaban R, Pomerantz SH, Marshall S, Lambert DT, Lerner AB. Regulation of tyrosinase in human melanocytes grown in culture. J Cell Biol 1983; 97:480-488.
38. Jimenez M, Tsukamoto K, Hearing VJ. Tyrosinases from two different loci are expressed by normal and transformed melanocytes. J Biol Chem 1991; 266:1147-1156.
39. Baharav E, Merimsky O, Altomonte M, Shoenfeld Y, Pavlovic M, Maio M, et al. Anti-tyrosinase antibodies participate in the immune response to vaccination with anti-idiotypic antibodies mimicking the high-molecular-weight melanoma-associated antigen. Melanoma Res 1995; 5:337-343.
40. Clynes R, Yoshizumi T, Yoichi M, Houghton A, Ravetch JV. Fc receptors are required in passive and active immunity to melanoma. Proc Natl Acad Sci USA 1998; 95:652-656.
41. Kemp EH, Waterman EA, Gawkrodger DJ, Watson PF, Weetman AP. Identification of epitopes on tyrosinase which are recognized by autoantibodies from patients with vitiligo. J Invest Dermatol 1999; 113:267-271.
42. Kirkin AF, Dzhandzhugazyan K, Zeuthen J. The immunogenic properties of melanoma-associated antigens recognized by cytotoxic T lymphocytes. Exp Clin Immunogenet 1998; 15:19-32.
43. Kawakami Y, Robbins PF, Wang X, Tupesis JP, Parkhurst MR, Kang X, et al. Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles. J Immunol 1998; 161:6985-6992.
44. Kang X, Kawakami Y, el-Gamil M, Wang R, Sakaguchi K, Yannelli JR, et al. Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes. J Immunol 1995; 155:1343-1348.
45. Koch M, Murrell JR, Hunter DD, Olson PF, Jin W, Keene DR, et al. A novel member of the netrin family, β-netrin, shares homology with the β chain of laminin: identification, expression, and functional characterisation. J Cell Biol 2000; 151:221-234.
46. Tomita Y, Montague PM, Hearing VJ. Anti-T4-tyrosinase monoclonal antibodies-specific markers for pigmented melanocytes. J Invest Dermatol 1985; 85:426-430.
47. Jiménes M, Tsukamoto K, Hearing VJ. Tyrosinases from two different loci are expressed by normal and by transformed melanocytes. J Biol Chem 1991; 266:1147-1156.